H. Scholl

426 total citations
18 papers, 359 citations indexed

About

H. Scholl is a scholar working on Pharmacology, Oncology and Epidemiology. According to data from OpenAlex, H. Scholl has authored 18 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 8 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in H. Scholl's work include Antibiotics Pharmacokinetics and Efficacy (12 papers), Pneumonia and Respiratory Infections (4 papers) and Neutropenia and Cancer Infections (3 papers). H. Scholl is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (12 papers), Pneumonia and Respiratory Infections (4 papers) and Neutropenia and Cancer Infections (3 papers). H. Scholl collaborates with scholars based in Germany, Iceland and Norway. H. Scholl's co-authors include R. Rohwedder, Tom Bergan, Sigurður B. Þorsteinsson, B. Weber, Kathrin Schmidt, Michael M. Iba, J Alam, Thomas K. H. Chang, John J. Fung and G. Stöcklin and has published in prestigious journals such as The American Journal of Medicine, Antimicrobial Agents and Chemotherapy and Diagnostic Microbiology and Infectious Disease.

In The Last Decade

H. Scholl

18 papers receiving 341 citations

Peers

H. Scholl
Comparison fields: 5 of 70
  • Pharmacology 222
  • Oncology 97
  • Epidemiology 88
  • Molecular Medicine 66
  • Molecular Biology 59
Replace D. Beermann with:
D. Beermann Germany
Vijay O. Bhargava United States
V. Malerczyk Germany
R. Wayne Frost United States
G. Mahr Germany
Hannu Sundquist Finland
J.L. Demetriades United States
John S. Wold United States
K Bachmann United States
Robert L. Kunka United States
D. Beermann Germany View profile →
Citations per field, relative to H. Scholl
H. Scholl · 1×
Citations per year, relative to H. Scholl
H. Scholl · 1×

Countries citing papers authored by H. Scholl

Since Specialization
Citations

This map shows the geographic impact of H. Scholl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Scholl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Scholl more than expected).

Fields of papers citing papers by H. Scholl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Scholl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Scholl. The network helps show where H. Scholl may publish in the future.

Co-authorship network of co-authors of H. Scholl

This figure shows the co-authorship network connecting the top 25 collaborators of H. Scholl. A scholar is included among the top collaborators of H. Scholl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Scholl. H. Scholl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
# Work Indexed citations
1 39
2 11
3 4
4 21
5
The distribution of ciprofloxacin and its metabolites in human plasma, pulmonary and bronchial tissues.
10
6 52
7 77
8 1
9 14
10 14
11 13
12
Perioperative prophylaxis in colorectal surgery: is a single shot with 200 mg ciprofloxacin sufficient to maintain therapeutic levels in gut tissues?
1
13
Bronchopulmonary penetration of ciprofloxacin.
1
14 61
15
One versus three doses of metronidazole/mezlocillin for antibiotic prophylaxis in colon surgery.
4
16
Pharmacokinetics of ciprofloxacin. 2nd communication: distribution to and elimination from tissues and organs following single or repeated administration of [14C]ciprofloxacin in albino rats.
15
17
Bromine-75-labeled 1,4-benzodiazepines: potential agents for the mapping of benzodiazepine receptors in vivo: concise communication.
19
18
A potential benzodiazepine receptor-binding radiopharmaceutical for positron emission tomography: [ 75 Br]-7-bromo-1,3-dihydro-5-(2'-fluorophenyl)-1-methyl-2H-1,4-benzodiazepine-2-one ([ 75 Br]-BFB)
2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026